Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DEFERRED TAX ASSETS (Details)

v3.24.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating losses $ 20,816,000 $ 1,198,000
Stock based compensation 3,035,000 148,000
Interest expense 179,000
Accounts receivable reserve 121,000
Contributions carryover 285,000
Research and development credits 839,000
Intangibles (8,358,000)
Inventory (361,000)
Related party accrual 2,000
Research and development costs 27,000 7,000
Total deferred tax assets: 16,628,000 1,355,000
Less valuation allowance (16,182,000) (1,355,000)
Net deferred tax assets (liability)